Inclisiran's therapeutic goal includes reducing which lipid parameter?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Inclisiran's therapeutic goal includes reducing which lipid parameter?

Inclisiran lowers LDL-C by silencing PCSK9 production in the liver. With less PCSK9, more LDL receptors remain on hepatocytes to clear LDL particles from the blood, so LDL-cholesterol levels fall. This makes reducing LDL-C the therapeutic goal. It does not dramatically raise HDL-C, and it does not increase LDL-C or have no effect on cholesterol.

Inclisiran lowers LDL-C by silencing PCSK9 production in the liver. With less PCSK9, more LDL receptors remain on hepatocytes to clear LDL particles from the blood, so LDL-cholesterol levels fall. This makes reducing LDL-C the therapeutic goal. It does not dramatically raise HDL-C, and it does not increase LDL-C or have no effect on cholesterol.

More practice questions